Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer (Q35569694)
Jump to navigation
Jump to search
scientific article published on 3 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer |
scientific article published on 3 May 2011 |
Statements
1 reference
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer (English)
1 reference
Clifford Hudis
1 reference
Joseph A Sparano
1 reference
Ayca Gucalp
1 reference
James Caravelli
1 reference
Jean Santamauro
1 reference
Sujata Patil
1 reference
Alyson Abbruzzi
1 reference
Christine Pellegrino
1 reference
Jackie Bromberg
1 reference
Chau Dang
1 reference
Maria Theodoulou
1 reference
Tiffany A Traina
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference